Effect of vitamin D3 supplementation on Staphylococcus aureus nasal carriage: A randomized, double-blind, placebo-controlled trial in healthy adults

Clinical Microbiology and Infection

Volumn 20, Issue 5, 2014, Pages 453-458

  Slow, S ^a   Priest, P C ^b   Chambers, S T ^a,c   Stewart, A W ^d   Jennings, L C ^a,e   Florkowski, C M ^a,e   Livesey, J H ^e   Camargo, C A ^f   Scragg, R ^d   Murdoch, D R ^a,e  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c CHRISTCHURCH HOSPITAL   (New Zealand)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e CANTERBURY HEALTH LABORATORIES   (New Zealand)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Randomized controlled trial; Risk factors of nasal carriage; Serum 25 hydroxy vitamin D; Staphylococcus aureus nasal carriage; Vitamin D3 supplementation

Indexed keywords

COLECALCIFEROL; PLACEBO; 25-HYDROXYVITAMIN D; VITAMIN; VITAMIN D;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CARRIER; BACTERIUM CULTURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NOSE SMEAR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; RISK FACTOR; SEX DIFFERENCE; STAPHYLOCOCCUS AUREUS; TANDEM MASS SPECTROMETRY; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG THERAPY; HETEROZYGOTE; MICROBIOLOGY; MIDDLE AGED; NORMAL HUMAN; NOSE;

STAPHYLOCOCCUS AUREUS;

ADULT; CARRIER STATE; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HEALTHY VOLUNTEERS; HUMANS; MALE; MIDDLE AGED; NOSE; SEX FACTORS; STAPHYLOCOCCUS AUREUS; VITAMIN D; VITAMINS;

EID: 84901605632     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12350     Document Type: Article

References (28)

1. Kluytmans J, vanBelkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms and associated risks. Clin Microbiol Rev 1997; 10: 505-520.
2. vonEiff C, Becker K, Machka K, Stammer H, Peters G for the Study Group. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med. 2001; 344: 11-16.
3. Wertheim HFL, Melles DC, Vos MC et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005; 5: 751-762.
4. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-532.
5. Lamers RP, Stinnett JW, Muthukrishnan K, Parkinson CL. Evolutionary analyses of Staphylococcus aureus identify genetic relationships between nasal carriage and clinical isolates. PLoS ONE 2011; 6: e16426.
6. vanBelkum A, Melles DC, Nouwen J et al. Co-evolutionary aspects of human colonization and infection of Staphylococcus aureus. Infect Genet Evol 2009; 9: 32-47.
7. Muthukrishan G, Quinn GA, Lamers RP et al. Exoproteome of Staphylococcus aureus reveals putative determinants of nasal carriage. J Proteome Res 2011; 10: 2064-2078.
8. Peacock SJ, Justice A, Griffiths D et al. Determinants of acquisition and carriage of Staphylococcus aureus in infancy. J Clin Microbiol 2003; 41: 5718-5725.
9. Shopsin B, Mathema B, Martinez J et al. Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community. J Infect Dis 2000; 182: 359-362.
10. Williams REO. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev 1963; 27: 56-71.
11. Cole AM, Tahk S, Oren A et al. Determinants of Staphylococcus aureus nasal carriage. Clin Diagn Lab Immunol 2001; 8: 1064-1069.
12. Herwaldt LA, Cullen JC, French P et al. Preoperative risk factors for nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol, 2004; 25: 481-484.
13. Lasseter G, Charlett A, Lewis D, Donald I, Howell-Jones R, McNulty CAM. Staphylococcus aureus carriage in care homes: identification of risk factors, including the role of dementia. Epidemiol Infect 2010; 138: 686-696.
14. Mainous AG III, Hueston WJ, Everett CJ, Diaz VA. Nasal carriage of Staphylococcus aureus and methicillin-resistant S. aureus in the United States, 2001-2002. Ann Fam Med 2006; 4: 132-137.
15. Charlebois ED, Bangsburg DR, Moss NJ et al. Population-base community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis 2002; 34: 425-433.
16. Gorwitz RJ, Kruszon-Moran D, McAllister SK et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States 2001-2004. J Infect Dis 2008; 197: 1226-1234.
17. Smith TC, Forshey BM, Hanson BM, Wardyn SE, Moritz ED. Molecular and epidemiologic predictors of Staphylococcus aureus colonization site in a population with limited nosocomial exposure. Am J Infect Control 2012; 40: 992-996.
18. Olsen K, Falch BM, Danielsen K et al. Staphylococcus aureus nasal carriage is associated with serum 25-hydroxy vitamin D levels, gender and smoking status the Tromsø Staph and skin study. Eur J Clin Microbiol Infect Dis 2012; 31: 465-473.
19. Wang JT, Liao C-H, Fang C-T et al. Prevalence of and risk factors for colonization by methicillin resistant Staphylococcus aureus among adults in community settings in Taiwan. J Clin Microbiol 2009; 47: 2957-2963.
20. Olsen K, Sangvik M, Simonsen GS et al. Prevalence and population structure of Staphylococcus aureus nasal carriage in healthcare workers in a general population the Tromsø Staph and skin study. Epidemiol Infect 2013; 141: 143-152.
21. Zanger P, Nurjadi D, Gaile M, Gabrysch S, Kremsner PG. Hormonal contraceptive use and persistent Staphylococcus aureus nasal carriage. Clin Infect Dis 2012; 55: 1625-1632.
22. Matheson EM, Mainous AG III, Hueston WJ, Diaz VA, Everett CJ. Vitamin D and methicillin-resistant Staphylococcus aureus nasal carriage. Scand J Infect Dis 2010; 42: 455-460.
23. Dean SN, Bishop BM, vanHoek ML. Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus. BMC Microbiol 2011; 11: 114-125.
24. Murdoch DR, Slow S, Chambers ST et al. Effect of vitamin D3 supplementation on upper respiratory infections in healthy adults: a randomized, double blind, placebo-controlled trial. JAMA 2012; 308: 1333-1339.
25. Salmond C, Crampton P, Atkinson J. NZDep2006 index of deprivation. Wellington, New Zealand: Department of Public Health, University of Otago, 2007.
26. Martineau AR. Bolus dose vitamin D and prevention of childhood pneumonia. Lancet 2012; 379: 1373-1375.
27. vanBelkum A, Verkaik NJ, deVogel CP et al. Reclassification of Staphylococcus aureus nasal carriage types. J Infect Dis 2009; 199: 1820-1826.
28. Verhoeven PO, Grattard F, Carricajo A et al. An algorithm based on one or two nasal samples is accurate to identify persistent nasal carriers of Staphylococcus aureus. Clin Microbiol Infect 2012; 18: 551-557.